Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Elite Pharma Inc (OP: ELTP ) 0.5600 +0.0249 (+4.65%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,767,556 Open 0.5589 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.5351 Today's Range 0.5500 - 0.5600 52wk Range 0.1213 - 0.7549 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R) Today 7:00 EST Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty... Via Newsfile Exposures Product Safety Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets December 02, 2024 Northvale, New Jersey--(Newsfile Corp. - December 2, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty... Via Newsfile Exposures Product Safety Performance YTD +302.01% +302.01% 1 Month -7.61% -7.61% 3 Month +44.33% +44.33% 6 Month +212.85% +212.85% 1 Year +305.80% +305.80% More News Read More Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse November 18, 2024 Via Newsfile Exposures Product Safety Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information November 14, 2024 Via Newsfile Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information February 14, 2024 Via ACCESSWIRE Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information November 14, 2023 Via ACCESSWIRE Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024 November 07, 2024 Via Newsfile Exposures Product Safety Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health October 10, 2024 Via Newsfile Exposures Product Safety Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets October 07, 2024 Via Newsfile Top Analyst Reports For Nvidia, American Express & Wells Fargo September 27, 2024 Via Talk Markets Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium August 27, 2024 Via Newsfile ELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q1 2025 August 14, 2024 Via InvestorPlace Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information August 14, 2024 Via Newsfile Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024 August 09, 2024 Via Newsfile ELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q4 2024 July 11, 2024 Via InvestorPlace Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information July 01, 2024 Via Newsfile Treasure Hunt: 7 Penny Stocks Wall Street Hasn’t Discovered Yet June 27, 2024 Via InvestorPlace Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024 June 26, 2024 Via Newsfile Exposures Product Safety 7 Strong Buy Penny Stocks to Buy Now: June 2024 June 13, 2024 Via InvestorPlace Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate May 20, 2024 Via ACCESSWIRE Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024 February 08, 2024 Via ACCESSWIRE Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant December 26, 2023 Via ACCESSWIRE Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC December 12, 2023 Via ACCESSWIRE Small Stocks, Big Potential: 7 Penny Stocks Poised for Major Gains in 2024 December 04, 2023 Via InvestorPlace Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023 November 10, 2023 Via ACCESSWIRE Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
